Please ensure Javascript is enabled for purposes of website accessibility CIRCULAR (NO.22)FDA adds Boxed Warning for increased risk of death with gout medicine Uloric( Febuxostat) CIRCULAR (NO.22)FDA adds Boxed Warning for increased risk of death with gout medicine Uloric( Febuxostat)
Alert :

Welcome to the beta version of the eHealth portal; our goal is to improve your experience by providing better eServices

CIRCULAR (NO.22)FDA adds Boxed Warning for increased risk of death with gout medicine Uloric( Febuxostat)

CIRCULAR (NO.22)FDA adds Boxed Warning for increased risk of death with gout medicine Uloric( Febuxostat)

Content Details
Pharmacovigilance and drug information Department News and Safety Alerts
CIRCULAR (NO.22)FDA adds Boxed Warning for increased risk of death with gout medicine Uloric( Febuxostat)
01/01/2019

CIRCULAR (NO.22)FDA adds Boxed Warning for increased risk of death with gout medicine Uloric( Febuxostat)

View Download
1
CIRCULAR (NO.22)FDA adds Boxed Warning for increased risk of death with gout medicine Uloric( Febuxostat)
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

Share this page
Follow Us On